Molecular Mechanisms and New Treatment Paradigm for Atrial Fibrillation

BACKGROUND: Atrial fibrillation (AF) represents the most common arrhythmia leading to increased morbidity and mortality, yet, current treatment strategies have proven inadequate. Conventional treatment with antiarrhythmic drugs carries a high risk for proarrhythmias. The soluble epoxide hydrolase en...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Circ Arrhythm Electrophysiol
Autors principals: Sirish, Padmini, Li, Ning, Timofeyev, Valeriy, Zhang, Xiao-Dong, Wang, Lianguo, Yang, Jun, Lee, Kin Sing S., Bettaieb, Ahmed, Ma, Sin Mei, Lee, Jeong Han, Su, Demetria, Lau, Victor C., Myers, Richard E., Lieu, Deborah K., López, Javier E., Young, J. Nilas, Yamoah, Ebenezer N., Haj, Fawaz, Ripplinger, Crystal M., Hammock, Bruce D., Chiamvimonvat, Nipavan
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4869994/
https://ncbi.nlm.nih.gov/pubmed/27162031
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCEP.115.003721
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars